[Multidisciplinary treatment of esophageal cancer].
It is well known that surgical treatment is a major therapy on esophageal carcinoma. But the prognosis of the operated patients has not been yet satisfactory due to high frequency of recurrence. Therefore effective adjuvant therapy is necessary pre and/or post operatively such as radiation therapy, chemotherapy, immunotherapy and hyperthermia, etc. However, there is no general method of combination therapy with operation, since each patient shows different sensitivity to adjuvant therapy. This paper summarized that an appropriate multidisciplinary therapy had been carried on each case.
Fujimaki
M
M
D000328:Adult; D000368:Aged; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011879:Radiotherapy Dosage; D005641:Tegafur / Q000008:administration & dosage
D001761:Bleomycin; D005641:Tegafur; D002945:Cisplatin